1-3 of 3
Richard Fong, PharmD
Close
Sort by
Journal Articles

Direct Oral Anticoagulants (DOACs) Vs. Low Molecular Weight Heparins (LMWH) for Venous Thromboembolism (VTE) in Patients with Primary Brain Tumors or Secondary Brain Metastases

Angela Lee, PharmD, Frank Oley, Jr., PharmD, Mimi Lo, PharmD, BCPS, BCOP, Richard Fong, PharmD, BCOP, Mary McGann, PharmD, Ila Saunders, PharmD, BCOP, Shanna Block, PharmD, BCOP, Anjlee Mahajan, MD, Tiffany Pon, PharmD, BCPS
Journal: Blood
Blood (2020) 136 (Supplement 1): 6.
https://doi.org/10.1182/blood-2020-138635
Published: 2020
Journal Articles

Retrospective Analysis of Modified Hyper-CVAD Therapy Combined with Proteasome Inhibition for Patients with Multiple Myeloma and Renal Insufficiency or Renal Failure

Derek Galligan, MD, Rupa Narayan, MD, Sarah Kim, PharmD, Ann Lazar, PhD MS, Marisela Tan, PharmD, Richard Fong, PharmD, Mimi Lo, PharmD, Nina Shah, MD, Shagun Arora, MD, Sandy W. Wong, MD, Thomas G. Martin, III, MD, Jeffrey Lee Wolf, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3236.
https://doi.org/10.1182/blood-2018-99-111625
Published: 2018
Journal Articles

Frequency, Risk Factors and Mortality Effect of Venous Thromboembolism in Adult Patients with Central Nervous System Lymphoma

Anjlee Mahajan, MD, Son Ho, PharmD, Mimi Lo, PharmD, James L. Rubenstein, MD PhD, Richard Fong, PharmD
Journal: Blood
Blood (2015) 126 (23): 4458.
https://doi.org/10.1182/blood.V126.23.4458.4458
Published: 2015